Israel Discount Bank of New York’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-200
Closed -$38K – 95
2019
Q1
$38K Hold
200
– – 0.03% 255
2018
Q4
$39K Hold
200
– – 0.03% 236
2018
Q3
$41K Hold
200
– – 0.03% 245
2018
Q2
$37K Hold
200
– – 0.02% 327
2018
Q1
$34K Hold
200
– – 0.02% 336
2017
Q4
$35K Hold
200
– – 0.02% 339
2017
Q3
$37K Hold
200
– – 0.03% 321
2017
Q2
$34K Hold
200
– – 0.03% 327
2017
Q1
$33K Sell
200
-1,530
-88% -$254K 0.03% 319
2016
Q4
$253K Buy
+1,730
New +$260K 0.23% 77

Other funds holding AMGN

Israel Discount Bank of New York's AMGN Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of Amgen (AMGN) in Q2 2019, closing a stake of 200 shares — an estimated $38K sold.

Israel Discount Bank of New York first reported a position in AMGN in Q4 2016 and held it in 10 quarters. The position peaked at $253K in Q4 2016. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Israel Discount Bank of New York reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Israel Discount Bank of New York sold 200 Amgen shares in Q2 2019, an estimated $38K.
  • Israel Discount Bank of New York first reported a position in Amgen in Q4 2016 and held it in 10 quarters.
  • Israel Discount Bank of New York's Amgen position peaked at $253K in Q4 2016.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.